Format

Send to

Choose Destination
Virology. 2008 Dec 20;382(2):257-66. doi: 10.1016/j.virol.2008.09.018. Epub 2008 Oct 31.

Epstein-Barr virus growth/latency III program alters cellular microRNA expression.

Author information

1
Louisiana Cancer Research Consortium, Tulane University Health Sciences Center, 1430 Tulane Avenue, SL79, New Orleans, LA 70112, USA. jcamero1@tulane.edu

Abstract

The Epstein-Barr virus (EBV) is associated with lymphoid and epithelial cancers. Initial EBV infection alters lymphocyte gene expression, inducing cellular proliferation and differentiation as the virus transitions through consecutive latency transcription programs. Cellular microRNAs (miRNAs) are important regulators of signaling pathways and are implicated in carcinogenesis. The extent to which EBV exploits cellular miRNAs is unknown. Using micro-array analysis and quantitative PCR, we demonstrate differential expression of cellular miRNAs in type III versus type I EBV latency including elevated expression of miR-21, miR-23a, miR-24, miR-27a, miR-34a, miR-146a and b, and miR-155. In contrast, miR-28 expression was found to be lower in type III latency. The EBV-mediated regulation of cellular miRNAs may contribute to EBV signaling and associated cancers.

PMID:
18950829
PMCID:
PMC2640950
DOI:
10.1016/j.virol.2008.09.018
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center